Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: The Fierce 50 of 2024
Recro Pharma
Pharma
CoreRx moves to purchase Societal CDMO in $130M cash deal
Several months after Societal CDMO launched a restructuring campaign, the small molecule manufacturer has announced it’s being bought out.
Fraiser Kansteiner
Feb 29, 2024 9:41am
Recro Pharma rebrands itself as Societal CDMO
Mar 22, 2022 7:15am
Recro plots $50M deal to buy Irisys and take CDMO biz bi-coastal
Aug 16, 2021 12:01pm
Recro and Novartis extend pact—News of Note
Feb 13, 2019 2:04pm
Recro Pharma expands CDMO business in Georgia
Nov 7, 2018 11:46am
